Lysolecithin derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5310958
SERIAL NO

07832585

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A modified biologically active protein consisting essentially of a biologically active protein bonded to lecithin via a covalent linking group and a pharmaceutical composition comprising the modified biologically active protein in a pharmaceutically acceptable carrier. The biologically active proteins include antibodies, superoxide dismutase, insulin and callidinogenase. Lecithin derivatives are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LTT BIO-PHARMA CO LTDMINATO-KU TOKYO 105-0022

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mizushima, Yutaka 4-25-20, Daida, Setagaya-ku, Tokyo, JP 38 509

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation